AGENT FOR TREATING MEIBOMIAN GLAND DYSFUNCTION

WIPO Patent Application WO/2014/208709

A1

The purpose of the present invention is to provide an agent for treating meibomian gland dysfunction. The present invention provides an agent for treating meibomian gland dysfunction, the agent containing activated vitamin D3 or a derivative thereof as an active ingredient.

JP2018500375	Use of 2-methylene-19-nor- (20S) -1α,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism
WO/2006/074226	PREVENTION OF THROMBOTIC DISORDERS WITH ACTIVE VITAMIN D COMPOUNDS OR MIMICS THEREOF
WO/2021/116188	COMBINATION PRODUCT CONTRIBUTING TO THE WELL-BEING OF PREGNANT WOMEN, COMPRISING EPA, DHA, VITAMINS AND MINERALS

TSUBOTA KAZUO (JP)
ARITA REIKO (JP)
ITO MASATAKA (JP)

PCT/JP2014/067099

December 31, 2014

June 27, 2014

Click for automatic bibliography generation  

UNIV KEIO (JP)

A61K31/593; A61K9/06; A61P3/06; A61P27/02; A61P29/00

WO1996029079A1

1996-09-26

JP2013087067A	2013-05-13
JP3738450B2	2006-01-25
JPH10316574A	1998-12-02

B.D.SULLIVAN ET AL.: "Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjogren's syndrome", ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, vol. 506, no. PT A, 2002, pages 441 - 447, XP055257181
FOULKS GN; BRON AJ, OCUL SURF, vol. 1, 2003, pages 107 - 126
GUTGESELL VJ; STERN GA; HOOD CI, AM J OPHTHALMOL, vol. 94, 1982, pages 383 - 387
SHIRO AMANO ET AL., JOURNAL OF THE EYE, vol. 27, no. 5, 2010, pages 627 - 631

TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)

View/Download PDF      PDF Help

Previous Patent: POWER RECEIVING APPARATUS, CONTROL METHOD, AND STORAGE MEDIUM

Next Patent: LAMINATED ARTICLE AND METHOD FOR MANUFACTURING SAME